Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?
Falcone
M
M
Giannella
M
M
Raponi
G
G
Mancini
C
C
Venditti
M
M
D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology* / Q000517:prevention & control; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology* / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D006801:Humans; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D041162:Staphylococcus haemolyticus / Q000187:drug effects* / Q000302:isolation & purification; D017334:Teicoplanin / Q000494:pharmacology / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D017334:Teicoplanin